The Health Resources and Services Administration (HRSA) updated its guidelines for cervical cancer screenings in April, introducing new options for women ages 30 to 65. The changes come as the American Cancer Society estimates more than 13,000 new cases of invasive cervical cancer will be diagnosed in 2026 and over 4,000 women will die from the disease.
Cervical cancer prevention remains a priority despite an 80% drop in rates since the introduction of the human papillomavirus (HPV) vaccine. Early detection is key to improving outcomes, making it important for women to stay informed about evolving screening protocols.
As of January 2026, federal guidelines allow women at average risk between ages 30 and 65 to choose a self-administered HPV test or self-collection method as a screening option. The test involves a vaginal swab performed in a private room at a doctor’s office. Insurance coverage for at-home versions is expected by 2027. However, officials caution that “a self-test is not a replacement for visiting your physician.” If results are positive, follow-up appointments are necessary so doctors can perform further tests such as Pap smears or colposcopies.
Screening recommendations vary by age group: Women aged 21–29 should have Pap smears every three years; those aged 30–65 may opt for doctor-collected HPV tests every five years or perform self-swab HPV tests every three years; and women over age 65 should consult their doctors about whether continued screening is needed if they have had normal results over the past decade.
Vaccination against HPV remains one of the most effective preventive measures. Current vaccines protect against virus types responsible for approximately ninety percent of cervical cancers and genital warts. The Centers for Disease Control and Prevention recommends two doses of the vaccine between ages nine and twelve, while teens and young adults up to age twenty-six who missed earlier vaccination should receive it as soon as possible. Individuals between twenty-seven and forty-five are advised to consult their healthcare providers regarding vaccination needs.
Clinicians often use both Pap smears and HPV testing together to identify abnormalities before they develop into cancer. Women who have had hysterectomies should discuss appropriate screening strategies with their physicians.
